These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. Polyzos SA; Anastasilakis AD; Efstathiadou Z; Kita M; Litsas I; Avramidis A; Arsos G; Moralidis E; Gerou S; Pavlidou V; Papatheodorou A; Terpos E Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154 [TBL] [Abstract][Full Text] [Related]
3. Dickkopf-1 as a potential therapeutic target in Paget's disease of bone. McCarthy HS; Marshall MJ Expert Opin Ther Targets; 2010 Feb; 14(2):221-30. PubMed ID: 20055719 [TBL] [Abstract][Full Text] [Related]
4. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395 [TBL] [Abstract][Full Text] [Related]
5. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761 [TBL] [Abstract][Full Text] [Related]
6. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Daoussis D; Liossis SN; Solomou EE; Tsanaktsi A; Bounia K; Karampetsou M; Yiannopoulos G; Andonopoulos AP Arthritis Rheum; 2010 Jan; 62(1):150-8. PubMed ID: 20039407 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma. Kaiser M; Mieth M; Liebisch P; Oberländer R; Rademacher J; Jakob C; Kleeberg L; Fleissner C; Braendle E; Peters M; Stover D; Sezer O; Heider U Eur J Haematol; 2008 Jun; 80(6):490-4. PubMed ID: 18331598 [TBL] [Abstract][Full Text] [Related]
8. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358 [TBL] [Abstract][Full Text] [Related]
10. Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone. Magnusson P; Davie MW; Sharp CA Scand J Clin Lab Invest; 2010 Apr; 70(2):128-35. PubMed ID: 20175736 [TBL] [Abstract][Full Text] [Related]
11. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. Rendina D; Gennari L; De Filippo G; Merlotti D; de Campora E; Fazioli F; Scarano G; Nuti R; Strazzullo P; Mossetti G J Bone Miner Res; 2006 Dec; 21(12):1828-35. PubMed ID: 17002563 [TBL] [Abstract][Full Text] [Related]
12. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation. Mangham DC; Davie MW; Grimer RJ Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007 [TBL] [Abstract][Full Text] [Related]
13. Bone alkaline phosphatase in Paget's disease. Deftos LJ; Wolfert RL; Hill CS Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067 [TBL] [Abstract][Full Text] [Related]
14. Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1. Polyzos SA; Anastasilakis AD; Litsas I; Sapranidis M; Efstathiadou Z; Kita M; Arsos G; Moralidis E; Zafeiriadou E; Papatheodorou A; Terpos E J Clin Densitom; 2010; 13(2):190-6. PubMed ID: 20347367 [TBL] [Abstract][Full Text] [Related]
15. Paget's disease of bone: presentation, extent and response to bisphosphonates. Wang LM; Au-Yeong ML; McKenna MJ Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502 [TBL] [Abstract][Full Text] [Related]
16. Role of Wnts in prostate cancer bone metastases. Hall CL; Kang S; MacDougald OA; Keller ET J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163 [TBL] [Abstract][Full Text] [Related]
17. Dickkopf-1: a suitable target for the management of myeloma bone disease. Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987 [TBL] [Abstract][Full Text] [Related]
19. Paget's disease of bone: experience from a centre in southern India. Anjali ; Thomas N; Rajaratnam S; Shanthly N; Oommen R; Seshadri MS J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899 [TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Heider U; Kaiser M; Mieth M; Lamottke B; Rademacher J; Jakob C; Braendle E; Stover D; Sezer O Eur J Haematol; 2009 Jan; 82(1):31-8. PubMed ID: 19067746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]